NOV 03, 2016 12:00 PM PDT

Point of Care Testing - Why Knowing Now Matters in the Emergency Department

Speaker
  • Director, Scientific Affairs, Abbott., Adjunct Assoc Professor of Pathology, Mount Sinai School of Medicine
    Biography
      Dr. Jacobs received his B.S. degree in Chemistry and Natural Sciences from Muhlenberg College in Allentown, PA and then obtained a Ph.D. in Biochemistry from the University of South Carolina. He did postdoctoral training in Clinical Chemistry & Toxicology at the University of North Carolina, Chapel Hill. Dr. Jacobs was a laboratory director at The Mount Sinai Hospital, Bellevue Medical Center and Henry J Carter and Coler-Goldwater Specialty Hospitals for over 25 years and has extensive experience with POCT, critical care testing, laboratory consolidation and automation, computerization and automatic result reporting, and planning and performance of clinical trials for various main laboratory and POCT systems. He has over 60 peer reviewed publications and textbook chapters and was the principal investigator on several beta site studies for various POCT analytical systems.

      Dr. Jacobs has been involved in establishing clinical diagnostic regulatory and accreditation standards at the local, national and international levels. He is a former director of the New York State laboratory accreditation program and is active in the Clinical and Laboratory Standards Institute. He is Chair of the CLSI Expert Panel on Point of Care Testing and was a member of the development committees for EP18 and EP23. Additionally, Dr. Jacobs is a past member, and current observer, of the US Technical Advisory Group for ISO Technical Committee 212 on Clinical Laboratory Testing and In Vitro Diagnostic Test Systems.

      Dr. Jacobs was the AACC Liaison to the Connectivity Industrial Consortium for POC Testing and was secretary & chair of both ANSA and the Point-of-Care Testing Division. He was a member of the NACB LMPG on Point of Care Testing Committee and is active in the International Federation of Clinical Chemistry. He is past chair of the Communications & Publications Division, was on several IFCC committees and working groups.

    Abstract

    There have been significant increases in emergency room visits across the US and delays in the ED leads to poor outcomes.  There is an association between waiting times and short term mortality and hospital admission.  Laboratory turnaround time can impact ED operations and, based on simulation modeling, the best performance is predicted when the TAT is 40 minutes or less.   The needs of every ED are different and this presentation will look at the impact of Point of Care testing on the provision of medical care and ED operations in three clinical conditions: chest pain (cardiac), sepsis (critical care) and infectious diseases.   

    Learning Objectives:

    • Understand the association between ED waiting times and short term mortality and hospital admissions.
    • Describe the operational benefits that can be achieved with a rapid chest pain disposition protocol.
    • Understand the role of lactate in the identification and monitoring of sepsis.
    • Explain the impact on key ED operational metrics of rapid infectious disease testing.

    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    APR 21, 2021 10:00 AM PDT
    C.E. CREDITS
    APR 21, 2021 10:00 AM PDT
    Date: April 21, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Serological testing for SARS-CoV-2 has been steadily adopted into clinical practice over the course of this pandemic. In this webinar,...
    APR 01, 2021 8:00 AM PDT
    C.E. CREDITS
    APR 01, 2021 8:00 AM PDT
    Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
    FEB 24, 2021 10:00 AM PST
    C.E. CREDITS
    FEB 24, 2021 10:00 AM PST
    DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
    DEC 03, 2020 4:30 PM PST
    C.E. CREDITS
    DEC 03, 2020 4:30 PM PST
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    NOV 03, 2016 12:00 PM PDT

    Point of Care Testing - Why Knowing Now Matters in the Emergency Department


    Specialty

    Research

    University

    Health

    Cell

    Research And Development

    Biotechnology

    Earth Science

    Personalized Medicine

    Molecular Biology

    Cancer Research

    Molecular Genetics

    Wellness

    Publishing

    Molecular Diagnostics

    Genetics

    Geography

    Asia75%

    North America25%

    Registration Source

    Website Visitors100%

    Job Title

    Clinical Laboratory Scientist33%

    Medical Laboratory Technician33%

    Engineer33%

    Organization

    Distribution/sales25%

    Clinical Laboratory25%

    Manufacturer - Other25%

    Other25%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more